Adipocytes impair leukemia treatment in mice

Cancer Research

Volumn 69, Issue 19, 2009, Pages 7867-7874

  Behan, James W ^a   Yun, Jason P ^a   Proektor, Marina P ^a   Ehsanipour, Ehsan A ^a   Arutyunyan, Anna ^a   Moses, Ara S ^a   Avramis, Vassilios I ^a,b,c   Louie, Stan G ^c,d   Butturini, Anna ^a,b,c   Heisterkamp, Nora ^a,b,c   Mittelman, Steven D ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DEXAMETHASONE; NILOTINIB; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN KINASE PIM 2; UNCLASSIFIED DRUG; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CELL CONTACT; CELL PROTECTION; CELL STRAIN 3T3; COCULTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL COMMUNICATION; COCULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; MALE; MICE; MICE, INBRED C57BL; OBESITY; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; VINCRISTINE;

EID: 70350231608     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0800     Document Type: Article

References (44)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638 (Pubitemid 36459468)
2. McTiernan, A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Huntingt) 2005;19:871-881 (Pubitemid 41725381)
3. El Serag HB. Obesity and disease of the esophagus and colon. Gastroenterol Clin North Am 2005;34:63-82.
4. Ross JA, Parker E, Blair CK, Cerhan JR, Folsom AR. Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 2004;13:1810-1813 (Pubitemid 39482961)
5. Hursting SD, Margolin BH, Switzer BR. Diet and human leukemia: an analysis of international data. Prev Med 1993;22:409-422
6. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 2008;122:1418-1421 (Pubitemid 351287244)
7. Whiteman MK, Hillis SD, Curtis KM, et al. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2005;14:2009-2014 (Pubitemid 41161216)
8. Freedland SJ, Grubb KA, Yiu SK, et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 2005;174:919-922
9. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203-211 (Pubitemid 40095871)
10. Pui CH. Childhood leukemias. N Engl J Med 1995;332: 1618-1630
11. Butturini A, Vignetti M, Gubbiotti S, et al. Obesity independently predicts event free survival (EFS) in Adults with BCR-ABL-negative acute lymphoblastic leukemia (ALL). A retrospective analysis of two GIMEMA studiefs. ASH Annual Meeting Abstracts 2005;106:1828.
12. Baillargeon J, Langevin AM, Lewis M, et al. Obesity and survival in a cohort of predominantly Hispanic children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2006;28:575-578 (Pubitemid 44496334)
13. Hijiya N, Panetta JC, Zhou Y, et al. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 2006;108:3997-4002. (Pubitemid 44913268)
14. Butturini AM, Dorey FJ, Lange BJ, et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25:2063-2069 (Pubitemid 46972792)
15. Zhang Y, Daquinag A, Traktuev DO, et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 2009;69:5259-5266
16. Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997;90:2723-2729
17. Lock RB, Liem N, Farnsworth ML, et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 2002;99:4100-4108 (Pubitemid 35332053)
18. Heisterkamp N, Jenster G, ten Hoeve J, et al. Acute leukaemia in bcr/abl transgenic mice. Nature 1990;344: 251-253
19. Mishra S, Zhang B, Groffen J, Heisterkamp N. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/ lymphoma caused by P190 Bcr/Abl. Leukemia 2004;18:23-28 (Pubitemid 38159435)
20. Jack I, Seshadri R, Garson M, et al. RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8. Cancer Genet Cytogenet 1986;19:261-269
21. Pegoraro L, Matera L, Ritz J, et al. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 1983;70:447-453
22. Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974;3:127-133
23. Wolins NE, Quaynor BK, Skinner JR, et al. OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis. J Lipid Res 2006;47:450-460
24. Liem NL, Papa RA, Milross CG, et al. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood 2004;103:3905-3914
25. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988;37:1163-1167 (Pubitemid 19035045)
26. Mudry RE, Fortney JE, York T, Hall BM, Gibson LF. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000;96:1926-1932 (Pubitemid 30661079)
27. Weisberg E, Wright RD, McMillin DW, et al. Stromalmediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther 2008;7:1121-1129
28. Lozzi GP, Massone C, Citarella L, Kerl H, Cerroni L. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol 2006;28:9-12. (Pubitemid 44366174)
29. Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009;460:259-263
30. Caers J, Deleu S, Belaid Z, et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia 2007; 21:1580-1584 (Pubitemid 46965308)
31. Frost BM, Forestier E, Gustafsson G, et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 2004;19:165-169 (Pubitemid 40090100)
32. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81:151-157 (Pubitemid 23013689)
33. Campos L, Rouault JP, Sabido O, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993;81:3091-3096 (Pubitemid 23162130)
34. Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 2005; 105:4477-4483
35. Zhang Y, Wang Z, Li X, Magnuson NS. Pim kinasedependent inhibition of c-Myc degradation. Oncogene 2008;27:4809-4819
36. Fox CJ, Hammerman PS, Cinalli RM, et al. The serine/ threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev 2003;17:1841-1854
37. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone 1996;19:421-428 (Pubitemid 126745119)
38. Di IN, Mittelman SD, Gilsanz V. Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults. Int J Obes (Lond) 2008;32:1854-1860
39. Cox J, Penn N, Masood M, Hancock AK, Parker D. Drug overdose-a hidden hazard of obesity. J R Soc Med 1987;80:708-709 (Pubitemid 18051565)
40. Fleming RA, Eldridge RM, Johnson CE, Stewart CF. Disposition of high-dose methotrexate in an obese cancer patient. Cancer 1991;68:1247-1250
41. Herrington JD, Tran HT, Riggs MW. Prospective evaluation of carboplatin AUCdosing in patients with a BMI> or = 27 or cachexia. Cancer Chemother Pharmacol 2006;57:241-247
42. Iyengar P, Combs TP, Shah SJ, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003;22:6408-6423 (Pubitemid 37281689)
43. Amemori S, Ootani A, Aoki S, et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro . Am J Physiol Gastrointest Liver Physiol 2007;292:G923-9.
44. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008;299:2401-2405